Diagnostic News and Research

RSS

XTend Medical provides update regarding the BioHarp market potential

XTend Medical, a company specializing in manufacturing and distributing the latest in telemedicine and diagnostic devices, released the following information regarding the BioHarp market potential.

12 Oct 2009

Orion Genomics enters collaboration and license agreement with Novartis Pharma

Orion Genomics today announced that it has entered into a multi-year collaboration and license agreement with the molecular diagnostics unit of Novartis Pharma AG. Under the collaboration, the parties seek to discover novel epigenetic biomarkers, and both parties have rights to independently develop and commercialize diagnostic products in their respective fields.

12 Oct 2009

OptumHealth’s conference to focus on advancements in fetal diagnosis and treatment

OptumHealth Inc. has teamed with The Children’s Hospital of Philadelphia (CHOP) to present a two-day educational conference focused on clinical advancements in fetal diagnosis and treatment, neonatal care and pediatric care. The gathering runs through today, and is part of OptumHealth’s Network Spotlight Conferences program.

12 Oct 2009

GE Healthcare launches global initiative to celebrate 10th anniversary of digital mammography

GE Healthcare (NYSE:GE) wishes to issue the following update and correction to its release NewsItemID 20090923005515 (GE-HEALTHCARE) "GE Healthcare Launches Global Initiative to Celebrate the 10th Anniversary of Digital Mammography" issued September 23, 2009/

12 Oct 2009

Federal stimulus funds for comparative-effectiveness research in cancer

Researchers at Fred Hutchinson Cancer Research Center, Group Health Research Institute and the University of Washington schools of Public Health and Pharmacy have been selected to lead four projects backed by approximately $16 million in federal stimulus funding for comparative-effectiveness research in cancer.

12 Oct 2009

Business update from Cardima

Cardima, Inc., a medical device company focused on the diagnosis and treatment of atrial fibrillation (“AF”), is providing the following update on its progress, recent activities and upcoming milestones.

12 Oct 2009

Rural Americans with heart disease at risk of impending Medicare cuts

Medicare regulatory changes expected to be finalized in November - but overshadowed by the partisan bluster of the ongoing health care debate - pose an imminent threat to 80 million patients in America suffering from heart disease, especially for the nearly one in four Americans over the age of 65 living in rural areas.

12 Oct 2009

CCHIT certifies Eclipsys’ PeakPractice EMR/PM solution

Eclipsys Corporation®, The Outcomes Company®, today announced that the Certification Commission for Health Information Technology (CCHIT®) has listed its PeakPractice™ solution (version 1093) a CCHIT Certified® 08 Ambulatory electronic health record (EHR), and meets the Certification Commission’s EHR criteria for office-based use.

12 Oct 2009

Public forum and scientific workshop on women's health issues

The Northwestern University Feinberg School of Medicine and Northwestern Memorial Hospital will host a public forum and scientific workshop Oct. 14 to 16 to discuss emerging issues of importance for the National Institutes of Health (NIH) for women's health research in the coming decade.

12 Oct 2009

Dilon Diagnostics and Philips sign distribution agreement

Dilon Diagnostics, the leader in molecular breast imaging (MBI) also known as Breast-Specific Gamma Imaging (BSGI) and Philips (NYSE: PHG, AEX: PHI), today announce that they have entered into a distribution agreement. Philips Healthcare will sell and support the Dilon 6800 gamma camera in key European and Middle Eastern markets. The compact camera technology and related products and services are used for the detection of breast cancer as an adjunct to mammography and serve to complement Philips innovative women's health solutions.

12 Oct 2009

Three hundred participants sought for world-first study to determine shared biological basis for psychotic illnesses

For the first time, sufferers of schizophrenia and bipolar disorder are being brought together in a major new study investigating the diseases' common genetic causes and manifestations.

11 Oct 2009

Health Discovery retains Dilenschneider Group to manage its investor and media relations work

Health Discovery Corporation, is pleased to announce that it has retained The Dilenschneider Group, headquartered in New York City, to manage the Company’s investor and media relations work. With offices in New York, Washington, DC and Chicago, the Dilenschneider Group provides its clients with some of the finest and most seasoned communications professionals in the world.

9 Oct 2009

Aperio's new digital slide sharing service for pathology incorporated as part of CAP’s Diagnostic Work Station

Aperio Technologies, Inc., a global leader in digital pathology for the healthcare and life sciences industry is pleased to announce that SecondSlide™, its newly launched digital slide sharing service for pathology, has been incorporated as one of the vendor solutions in the College of American Pathologists (CAP) prototype of the Diagnostic Work Station (DWS), a collaborative and heterogeneous vendor-neutral environment.

9 Oct 2009

Manual microdissection to remove biopsy cavities from breast cancer specimens essential

Genomic Health, Inc. today announced results from a study demonstrating the critical role of manual microdissection to remove all biopsy cavities from breast cancer specimens. Genomic Health's Oncotype DX is the only commercially available breast cancer test that employs manual microdissection following review by a board certified surgical pathologist with breast expertise to predict a patient's benefit from chemotherapy and risk of disease recurrence.

9 Oct 2009

Magnetic resonance imaging to help diagnose hidden prostate cancer

Clinical researchers at Princess Margaret Hospital (PMH) can now answer the question that baffles many clinicians - why do some men with elevated prostate specific antigen (PSA) levels who are carefully monitored and undergo repeated negative biopsies still develop aggressive prostate cancer?

9 Oct 2009

Cambridge Heart to showcase Microvolt T-Wave Alternans technology at 2009 Annual Meeting Conference

Cambridge Heart, Inc. (OTCBB-CAMH) will participate in the Sudden Cardiac Arrest Association’s 2nd Annual Meeting and Medical Education Conference in Chicago, Illinois October 9th through the 11th, to showcase their Microvolt T-Wave AlternansTM (MTWA) technology designed to identify patients at risk for Sudden Cardiac Arrest (SCA).

9 Oct 2009

HealthHelp to provide radiation oncology management on national scale

With cancer’s incidence and treatment costs rising, HealthHelp has become the first company to provide radiation oncology management on a national scale. Approximately 4 million Humana patients in 46 states will benefit from this innovative new program.

9 Oct 2009

Ipsen signs exclusive marketing agreement to produce and distribute Braintree's BLI-800 for colonic cleansing

Ipsen (Euronext: FR0010259150; IPN), an innovation-driven global specialty pharmaceutical Group and Braintree Laboratories, Inc., a US-based company specializing in the development, manufacturing and marketing of specialty pharmaceuticals, announced today the signature of an agreement for the exclusive manufacturing, marketing and distribution rights of Braintree’s proprietary formulation BLI-800 in colonic cleansing before colonoscopy, the best diagnostic procedure for colorectal cancer screening.

9 Oct 2009

Eastern Maine Medical Center to implement real-time patient flow management system

Eastern Maine Medical Center's (EMMC) newly renovated 32,000 square foot Imaging Center is the high-tech host to an array of outpatient services, including CT scans, MRIs, Digital Mammography, Diagnostic Cardiology, Radiography and Ultrasound. Centralizing these medical services allowed EMMC to not only expand their offerings, but also alleviate parking congestion, long patient wait times and rescheduling.

9 Oct 2009

Grifols USA to distribute AMDL Diagnostics' DR-70 Onko-Sure cancer test

Radient Pharmaceuticals Corporation, a US-based pharmaceutical company through its wholly-owned subsidiary AMDL Diagnostics, Inc. (ADI) announced today it has entered into an exclusive 5-year marketing and distribution agreement with Grifols USA, LLC.

9 Oct 2009

Diagnostic News and Research

XTend Medical provides update regarding the BioHarp market potential

Orion Genomics enters collaboration and license agreement with Novartis Pharma

OptumHealth’s conference to focus on advancements in fetal diagnosis and treatment

GE Healthcare launches global initiative to celebrate 10th anniversary of digital mammography

Federal stimulus funds for comparative-effectiveness research in cancer

Business update from Cardima

Rural Americans with heart disease at risk of impending Medicare cuts

CCHIT certifies Eclipsys’ PeakPractice EMR/PM solution

Public forum and scientific workshop on women's health issues

Dilon Diagnostics and Philips sign distribution agreement

Three hundred participants sought for world-first study to determine shared biological basis for psychotic illnesses

Health Discovery retains Dilenschneider Group to manage its investor and media relations work

Aperio's new digital slide sharing service for pathology incorporated as part of CAP’s Diagnostic Work Station

Manual microdissection to remove biopsy cavities from breast cancer specimens essential

Magnetic resonance imaging to help diagnose hidden prostate cancer

Cambridge Heart to showcase Microvolt T-Wave Alternans technology at 2009 Annual Meeting Conference

HealthHelp to provide radiation oncology management on national scale

Ipsen signs exclusive marketing agreement to produce and distribute Braintree's BLI-800 for colonic cleansing

Eastern Maine Medical Center to implement real-time patient flow management system

Grifols USA to distribute AMDL Diagnostics' DR-70 Onko-Sure cancer test

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News